IMAC (BACK) Revenue & Revenue Breakdown
IMAC Revenue Highlights
Latest Revenue (Y)
$5.20M
IMAC Revenue by Period
IMAC Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.20M | -67.89% |
| 2022-12-31 | $16.19M | 12.51% |
| 2021-12-31 | $14.39M | 12.08% |
| 2020-12-31 | $12.84M | -15.14% |
| 2019-12-31 | $15.13M | 125.73% |
| 2018-12-31 | $6.70M | 752.53% |
| 2017-12-31 | $786.02K | 5140.17% |
| 2016-12-31 | $15.00K | - |
IMAC generated $5.20M in revenue during NA 2023, up -67.89% compared to the previous quarter, and up 77.55% compared to the same period a year ago.
IMAC Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-5.00M | -419.52% |
| 2023-09-30 | $1.57M | 16.51% |
| 2023-06-30 | $1.34M | -35.80% |
| 2023-03-31 | $2.09M | -39.70% |
| 2022-12-31 | $3.47M | -8.32% |
| 2022-09-30 | $3.79M | -24.77% |
| 2022-06-30 | $5.03M | 29.22% |
| 2022-03-31 | $3.89M | -10.84% |
| 2021-12-31 | $4.37M | 25.26% |
| 2021-09-30 | $3.49M | 0.63% |
| 2021-06-30 | $3.47M | 13.09% |
| 2021-03-31 | $3.06M | -11.52% |
| 2020-12-31 | $3.46M | -0.42% |
| 2020-09-30 | $3.48M | 35.19% |
| 2020-06-30 | $2.57M | -22.55% |
| 2020-03-31 | $3.32M | -21.73% |
| 2019-12-31 | $4.24M | -2.58% |
| 2019-09-30 | $4.36M | 15.95% |
| 2019-06-30 | $3.76M | 35.63% |
| 2019-03-31 | $2.77M | -15.37% |
| 2018-12-31 | $3.27M | 29.59% |
| 2018-09-30 | $2.53M | 297.92% |
| 2018-06-30 | $634.70K | 136.96% |
| 2018-03-31 | $267.85K | -25.17% |
| 2017-12-31 | $357.96K | 16.69% |
| 2017-09-30 | $306.77K | - |
IMAC generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
IMAC Revenue Breakdown
IMAC Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 21 |
|---|---|
| Patient Revenues | $3.02M |
IMAC's latest quarterly revenue breakdown by segment (product or service), as of Mar 21: Patient Revenues (100.00%).
IMAC Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HCA | HCA Healthcare | $64.97B | $17.49B |
| AGL | agilon health | $4.32B | $1.48B |
| ACHC | Acadia Healthcare Company | $2.93B | $796.04M |
| CANO | Cano Health | $2.74B | $788.07M |
| AMED | Amedisys | $2.24B | $591.19M |
| AVAH | Aveanna Healthcare | $1.90B | $490.65M |
| PIII | P3 Health Partners | $1.27B | $388.49M |
| LFST | LifeStance Health Group | $1.06B | $300.44M |
| AIH | Aesthetic Medical Group | $682.59M | $181.64M |
| PNTG | Pennant Group | $544.89M | $156.91M |
| TOI | Oncology Institute | $324.24M | $94.67M |
| AIRS | AirSculpt | $195.92M | $51.00M |
| NVOS | Novo Integrated Sciences | $12.57M | $3.15M |
| BACK | IMAC | $5.20M | - |
| IONM | Assure | $255.00K | $9.00K |
BACK Revenue FAQ
What is IMAC’s yearly revenue?
IMAC's yearly revenue for 2023 was $5.2M, representing a decrease of -67.89% compared to 2022. The company's yearly revenue for 2022 was $16.19M, representing an increase of 12.51% compared to 2021. BACK's yearly revenue for 2021 was $14.39M, representing an increase of 12.08% compared to 2020.
What is IMAC’s quarterly revenue?
IMAC's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $-5.003M, a -419.52% decrease from the previous quarter (Q3 2023), and a -244.13% decrease year-over-year (Q4 2022). BACK's quarterly revenue for Q3 2023 was $1.57M, a 16.51% increase from the previous quarter (Q2 2023), and a -58.64% decrease year-over-year (Q3 2022).
What is IMAC’s revenue growth rate?
IMAC's revenue growth rate for the last 3 years (2021-2023) was -63.87%, and for the last 5 years (2019-2023) was -65.64%.